FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2
  • Home
  • About
  • Projects
    • P1 Lymph-Transplant
    • P2 Modulators of LA
    • N1 Ocular GvHD
    • N2 ABCB5 & Pterygium
    • P4 Ocular Melanoma
    • P5 Myeloid Cells
    • P6 Microglia in AMD
    • P8 Uveitis
    • C1 Eye Imaging
    • C2 Management
    • Publication highlights
  • Team
    • Executive Board
    • Research Groups
    • Central Projects
    • Associated projects
    • Alumni
  • Links
  • Events
    • Guest lectures
    • Retreats
    • Symposium
  • News

Prof. Langmann wins the Dr. Gaide AMD prize

Augenklinik

On 23 June 2018, Univ.-Prof. Dr. rer. nat. Thomas Langmann was awarded the Dr. Gaide AMD prize at the annual meeting of the Retina Society in Bonn. Prof. Langmann is the Chair of Experimental Immunology of the Eye in the Department of Ophthalmology, Medical Faculty, University of Cologne and Vice-Speaker of the DFG Research Unit For 2240 “Angiogenesis, Lymphangiogenesis and Cellular Immunity in Inflammatory Diseases of the Eye” based in Cologne.
The prize is endowed with a 10,000 euro award for excellence in research in the area of age-related macula degeneration (AMD), which is the primary cause of blindness for patients over the age of 60 in Western industrialized nations. As yet, there is no therapy for the so-called dry form of AMD, which leads to a high level of suffering for patients.
Prof. Langmann and his team are studying an inhibitor of chronic inflammation in the retina, the layers of tissue on the inner surface of the eyeball specialized for transforming light stimuli into nerve impulses. With AMD, so-called galectins are released, which are sugary protein molecules. If a harmonious way of blocking this process with drugs is found, then it will be possible to slow down the progression of AMD.

[This article is based in part on the German language item appearing on the website of University Hospital of Cologne on 2 July 2018:
http://intranet.uk-koeln.de/aktuelles-termine/uniklinik-intern/detailansicht/?tx_ttnews%5Btt_news%5D=1606&cHash=e68904bb7076b1f233855eb57e25f570]

Related posts

February 25, 2021

Eye clinic to win two renowned awards in the beginning of 2021


Read more
Zoom Meeting Shanghai

(v. l. n r.) Prof. Dr. med. Cursiefen, PD Dr. rer. nat. Felix Bock, Prof. Dr. med. Bi Yanglong Bi (top center)?), Prof. Dr. med. Takahiko Hayashi, PD Dr. med. Mario Matthaei

December 17, 2020

2nd Shanghai-Cologne Ophthalmic Research Meeting


Read more
November 6, 2020

FOR2240 Scientist Dr. Alexander C. Rokohl was selected for the Cologne Clinician Scientist Program


Read more

News

  • Eye clinic to win two renowned awards in the beginning of 2021
  • German Ophthalmological Society (DOG) – Professor Dr. Claus Cursiefen elected as Secretary General
  • 2nd Shanghai-Cologne Ophthalmic Research Meeting
  • Antonia Howaldt accepted into the Cologne Clinician Scientist Program
  • FOR2240 Scientist Dr. Alexander C. Rokohl was selected for the Cologne Clinician Scientist Program

More information

  • Publication highlights
  • Jobs
  • Contact
  • Impressum
  • Datenschutz

Newest publications

Supplemental Anti Vegf A-Therapy Prevents Rebound…(2020)


Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human…(2020)


Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional…(2020)


Contact

Esther Engel
Management Office
DFG Research Unit FOR2240
Department of Ophthalmology
University of Cologne
Kerpener Str. 62
50937 Cologne, Germany

www.for2240.de

Tel. +49 (0)221 478 32845
Fax. +49 (0)221 478 5094
esther.engel@uk-koeln.de

Partnerlogos

© 2021 FOR2240 | Online Marketing von Resulted Lübeck